These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16109434)

  • 21. Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.
    Patterson LJ; Malkevitch N; Zhao J; Peng B; Robert-Guroff M
    DNA Cell Biol; 2002 Sep; 21(9):627-35. PubMed ID: 12396605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
    Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
    J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
    Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys.
    Barouch DH; Letvin NL
    Dev Biol (Basel); 2000; 104():85-92. PubMed ID: 11713828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on Cellular Immune Responses of DNA Vaccine, rAd5 and rMVA Expressing SIV Gag/Env Gene Combined Immunization in Mice].
    He X; Chen D; Wang W; Xu K; Zeng Y; Feng X
    Bing Du Xue Bao; 2016 Mar; 32(2):170-8. PubMed ID: 27396160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.
    Wong SB; Siliciano RF
    J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M
    Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
    Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
    Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
    Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes.
    Van der Ryst E; Nakasone T; Habel A; Venet A; Gomard E; Altmeyer R; Girard M; Borman AM
    Res Virol; 1998; 149(1):5-20. PubMed ID: 9561560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.
    Nakaya Y; Nakaya T; Park MS; Cros J; Imanishi J; Palese P; García-Sastre A
    J Virol; 2004 Sep; 78(17):9366-75. PubMed ID: 15308731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys.
    Ou Y; Traina-Dorge V; Davis KA; Gray WL
    Virology; 2007 Aug; 364(2):291-300. PubMed ID: 17434552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev.
    Chenciner N; Randrianarison-Jewtoukoff V; Delpeyroux F; Hanania N; Pedroza Martins L; Stratford Perricaudet L; Perricaudet M; Wain-Hobson S
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):801-6. PubMed ID: 9171225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.
    Reyes-Sandoval A; Fitzgerald JC; Grant R; Roy S; Xiang ZQ; Li Y; Gao GP; Wilson JM; Ertl HC
    J Virol; 2004 Jul; 78(14):7392-9. PubMed ID: 15220412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.
    Bråve A; Hinkula J; Cafaro A; Eriksson LE; Srivastava IK; Magnani M; Ensoli B; Barnett SW; Wahren B; Rollman E
    Vaccine; 2007 Sep; 25(39-40):6882-90. PubMed ID: 17707956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Delta that expresses SIV Gag protein.
    Suzuki H; Kidokoro M; Fofana IB; Ohashi T; Okamura T; Matsuo K; Yamamoto N; Shida H
    Vaccine; 2009 Feb; 27(7):966-71. PubMed ID: 19135118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
    Billaut-Mulot O; Idziorek T; Loyens M; Capron A; Bahr GM
    Vaccine; 2001 Apr; 19(20-22):2803-11. PubMed ID: 11282190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.